| Mrs Tedra Hall, CAA | |
|
1 Baylor Plz, Houston, TX 77030-3498 | |
| (832) 355-2666 | |
| Not Available |
| Full Name | Mrs Tedra Hall |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 7 Years |
| Location | 1 Baylor Plz, Houston, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154943827 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Secondary |
| 367H00000X | Anesthesiologist Assistant | 32697619 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi St Luke's Health Baylor College Of Medicine Me | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baylor College Of Medicine | 8022243971 | 917 |
News Archive
A group of researchers at Seville University, headed by Isabel de los Reyes Rodríguez Ortiz, is analysing the reading comprehension processes of deaf youngsters, a factor closely linked to their level of expression, both verbal and using sign language.
The Leukemia & Lymphoma Society (LLS) and Shape Pharmaceuticals announced today that they have entered into a partnership to advance Shape's novel, topical treatment for cutaneous T-Cell lymphoma (CTCL) into clinical development. The compound, SHP-141, is a first-in-class topical histone deacetylase inhibitor with the potential to treat both early- and late-stage CTCL.
A recent review of research suggests that changes to the microorganisms (microbiota) in the gastrointestinal (GI) tract may be a cause of irritable bowel syndrome (IBS).
Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients respond to new immune-based treatments.
› Verified 3 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026664 PECOS PAC ID: 8022243971 Enrollment ID: O20131030000972 |
News Archive
A group of researchers at Seville University, headed by Isabel de los Reyes Rodríguez Ortiz, is analysing the reading comprehension processes of deaf youngsters, a factor closely linked to their level of expression, both verbal and using sign language.
The Leukemia & Lymphoma Society (LLS) and Shape Pharmaceuticals announced today that they have entered into a partnership to advance Shape's novel, topical treatment for cutaneous T-Cell lymphoma (CTCL) into clinical development. The compound, SHP-141, is a first-in-class topical histone deacetylase inhibitor with the potential to treat both early- and late-stage CTCL.
A recent review of research suggests that changes to the microorganisms (microbiota) in the gastrointestinal (GI) tract may be a cause of irritable bowel syndrome (IBS).
Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients respond to new immune-based treatments.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Tedra Hall, CAA 1333 Old Spanish Trl Apt 1168, Houston, TX 77054-1854 Ph: () - | Mrs Tedra Hall, CAA 1 Baylor Plz, Houston, TX 77030-3498 Ph: (832) 355-2666 |
News Archive
A group of researchers at Seville University, headed by Isabel de los Reyes Rodríguez Ortiz, is analysing the reading comprehension processes of deaf youngsters, a factor closely linked to their level of expression, both verbal and using sign language.
The Leukemia & Lymphoma Society (LLS) and Shape Pharmaceuticals announced today that they have entered into a partnership to advance Shape's novel, topical treatment for cutaneous T-Cell lymphoma (CTCL) into clinical development. The compound, SHP-141, is a first-in-class topical histone deacetylase inhibitor with the potential to treat both early- and late-stage CTCL.
A recent review of research suggests that changes to the microorganisms (microbiota) in the gastrointestinal (GI) tract may be a cause of irritable bowel syndrome (IBS).
Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients respond to new immune-based treatments.
› Verified 3 days ago
James Nast Trahan, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1500 Citywest Blvd Ste 300, Houston, TX 77042 Phone: 713-620-4000 | |
Caitlyn Marie Kohake, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 6720 Bertner Ave, Houston, TX 77030 Phone: 823-355-2666 | |
Robert Sean Mcneill, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1500 Citywest Blvd, Ste. 300, Houston, TX 77042 Phone: 713-620-4000 Fax: 713-458-4229 | |
Aleena A Gillani, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1500 Citywest Blvd Ste 300, Houston, TX 77042 Phone: 972-233-1999 Fax: 972-233-3666 | |
Logan Patrick Fettig, Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 6720 Bertner Ave, Houston, TX 77030 Phone: 832-355-2666 | |
Joseph Grant Shafer, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 6414 Fannin St, #g125, Houston, TX 77030 Phone: 713-500-6930 Fax: 713-500-5484 | |
Sarah P Her, AA-S Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1500 Citywest Blvd, Ste. 300, Houston, TX 77042 Phone: 713-620-4000 Fax: 713-458-4229 |